Survivorship Programs for the Cancer Survivor: Next steps for the Modern Cancer Patient
暂无分享,去创建一个
Fenghong Liu | M. Bishop-Jodoin | J. Aronowitz | L. Shanmugham | P. Rava | K. Banson | J. Glanzman | T. Fitzgerald | Yankhua Fan | L. Ding | H. Bushe | D. Goff | M. Cicchetti | Beth B. Herrick | I-lin Kuo | S. Sioshansi | Allison Sacher | J. Saleeby | C. Bradford | A. Khalifeh | John G. Roubil | Camelia Bunaciu | Daniel C. Han | Eric Ko | Su Yu | M. Bishop‐Jodoin
[1] B. Jeremic,et al. Radiation-induced lung toxicity – cellular and molecular mechanisms of pathogenesis, management, and literature review , 2020, Radiation oncology.
[2] N. Hanania,et al. Radiation-Induced Lung Injury: Assessment and Management. , 2019, Chest.
[3] J. Baima,et al. Positioning of port films for radiation: variability is present , 2018, Medical Oncology.
[4] Dinggang Shen,et al. Radiation‐induced brain structural and functional abnormalities in presymptomatic phase and outcome prediction , 2018, Human brain mapping.
[5] Sunil Krishnan,et al. Radiation-Induced Cardiovascular Disease: A Clinical Perspective , 2017, Front. Cardiovasc. Med..
[6] S. Huh,et al. Insufficiency fracture after radiation therapy , 2014, Radiation oncology journal.
[7] P. Hall,et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. , 2013, The New England journal of medicine.
[8] Joseph O Deasy,et al. Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): an introduction to the scientific issues. , 2010, International journal of radiation oncology, biology, physics.
[9] E. Yorke,et al. Use of normal tissue complication probability models in the clinic. , 2010, International journal of radiation oncology, biology, physics.
[10] R K Ten Haken,et al. Partial irradiation of the liver. , 2001, Seminars in radiation oncology.
[11] R. T. Ten Haken,et al. Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] J A Purdy,et al. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC) , 1999, International journal of radiation oncology, biology, physics.
[13] R K Ten Haken,et al. Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patients. , 1998, International journal of radiation oncology, biology, physics.
[14] M. Graham. Predicting radiation response. , 1997, International journal of radiation oncology, biology, physics.
[15] R. Jaszczak,et al. Quantification of radiation-induced regional lung injury with perfusion imaging. , 1997, International journal of radiation oncology, biology, physics.
[16] M. Goitein,et al. Tolerance of normal tissue to therapeutic irradiation. , 1991, International journal of radiation oncology, biology, physics.
[17] H. Withers,et al. Treatment volume and tissue tolerance. , 1988, International journal of radiation oncology, biology, physics.